🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Estrogen alters 3D genome looping, revealing key regulatory elements in endometrial cancer. 3D chromatin interactions are pivotal. #CancerGenomics PMID:40032586, Genome Res 2025 Oligonucleotide Therapeutics Society Nucleic Acids Res doi.org/10.1101/gr.279… #AI #Pharma #BioMed #RNA #ASHG #ESHG

🚀 Discover precision oncology with PRODE! It uses NIE & NICE scores from gene effects & protein interactions, outperforming traditional models. #GenomeBiology PMID:40022167, Genome Biol 2025 Oligonucleotide Therapeutics Society Nucleic Acids Res doi.org/10.1186/s13059… #AI #Pharma #BioMed #RNA #ASHG #ESHG

Auditor In a case where multiple conventional therapies failed, tx with #elsunersen succeeded. Preclinical studies had already established a mechanistic rationale for targeting SCN2A transcripts with #antisense oligos making the results expected and yet still extraordinary. Oligonucleotide Therapeutics Society

The OTS Education Committee wants to remind you that the OSWG White Papers are your go-to resource for oligonucleotide safety assessment! See them at: oligotherapeutics.org/oswg-whitepape… #ots #oligotherapeutics #oligonucleotide #biotech #biotechnology #science #research #medicalresearch

Unlock the future of your research. 🔑 The 21st Annual Meeting of the Oligonucleotide Therapeutics Society will connect you with industry experts and leading researchers who are shaping the future of oligo therapeutics. Register online now: 2025oligomeeting.com/registration #ots

2025 Oligomeeting – CAREER FAIR Where can a degree in nucleic acid therapeutics take you? Find out at the 2025 Oligomeeting CAREER EVENT on Sunday, October 19, at the Budapest Congress Center, Hungary! Free to attend, but pre-sign-up is required during conference registration

Join us on May 15, 2025, from 11-12pm EDT / 5-6pm CEST for our next Trainee Spotlight webinar featuring trainee Daniel van Leeuwen, poster award winner at the 2024 OTS Annual Meeting. Learn more and register at: oligotherapeutics.org/trainee-spotli… #ots #oligotherapeutics #webinar

Join us THIS WEEK for the next webinar in our Trainee Spotlight Series, Session 5. May 15, 2025, 11-12 pm EDT / 5-6 pm CEST. This session will feature Daniel van Leeuwen, PhD. Register at: oligotherapeutics.org/trainee-spotli… #ots #oligotherapeutics #webinar

Don’t miss the amazing events we have to bookend our 2025 Annual Meeting. These events are both made possible by our amazing sponsor, Chem Genes Corporation. Get more information at 2025oligomeeting.com/meeting-agenda. #ots #oligotherapeutics #oligonucleotide #ots25 #biotech

Holly Kordasiewicz has significantly contributed to research on validating targets for treating neurological diseases in preclinical model systems and identifying molecules suitable to advance to clinical testing for neurological diseases. oligotherapeutics.org/ots-member-hig… #ots

It’s time to submit your nominations for the Paper of the Year awards for the upcoming 2025 Annual Meeting. Nominations are open now through July 15, 2025, so make sure to nominate your choice NOW! oligotherapeutics.org/awards-grants/… #ots #oligotherapeutics #oligonucleotide #ots25

Today’s the day! Join us TODAY for the next webinar in our Trainee Spotlight Series, Session 5. Hear from Daniel van Leeuwen, PhD at 11-12 pm EDT / 5-6 pm CEST. Register NOW: oligotherapeutics.org/trainee-spotli… #ots #oligotherapeutics #webinar #oligonucleotidetherapeutics

CMC Challenges & Innovations – Let’s Talk! From ASO to mRNA - Join us at the OTS 2025 Lunch Session on CMC to dive into the critical challenges and innovations shaping the field. Pre-register to attend this session during your registration to the Oligomeeting #OTS2025 #CMC

Exploring 2 phenotypes in Snijders Blok-Campeau syndrome linked to CHD3. Zebrafish reveal unique behavioral traits. #GeneticResearch 🐠 PMID:39988727, Eur J Hum Genet 2025 Oligonucleotide Therapeutics Society Nucleic Acids Res doi.org/10.1038/s41431… #AI #Pharma #BioMed #RNA #ASHG #ESHG

Did you miss last week’s webinar? It is now available to watch on-demand at this link: oligotherapeutics.org/trainee-spotli… #ots #oligotherapeutics #webinar #oligonucleotidetherapeutics #geneticresearch #currentresearch

Did you know OTS members can access the Official Journal of OTS? The Official Journal of OTS is Nucleic Acid Therapeutics, which examines nucleic acids as therapeutic agents or modifying nucleic acids for therapeutic purposes. Learn more here: oligotherapeutics.org/journal/ #OTS

Submit your nominations for the Alan Gewirtz Awards by the July 15, 2025 deadline! Learn more details about eligibility requirements and how to apply here: oligotherapeutics.org/awards-grants/… #ots #oligotherapeutics #oligonucleotide #ots25 #biotech #biotechnology #scholarships #awards

At the OTS Annual meeting, there are a myriad of options for Sponsorship or Exhibiting. There are sponsorship and exhibit opportunities to accommodate every budget! Enquire now at 2025oligomeeting.com #ots #oligotherapeutics #oligonucleotide #ots25 #oligomeeting

We’re bringing Poster-Fire Sessions to the stage—giving students, post-docs, and trainees the chance to showcase their work in a concise, engaging format. Mark your interest when submitting your abstract after completing your Annual Meeting registration. October 20 & 21, 2025

Learn from the incoming OTS president, Rebecca Miles, during our webinar next month. June 12, 2025 11-12 pm EDT / 5-6 pm CEST. Register at: oligotherapeutics.org/perspectives-o… #ots #oligotherapeutics #oligonucleotide #biotech #biotechnology #science